The QualityStocks Daily Wednesday, June 5th, 2024

Today's Top 3 Investment Newsletters

360 Wall Street(ASNS) $3.7200 +691.49%

Premium Stock Alerts(NDRA) $0.1389 +63.41%

MarketClub Analysis(NVVE) $0.8680 +53.33%

The QualityStocks Daily Stock List

AAP Inc. (AAPJ)

We reported earlier on AAP Inc. (AAPJ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

AAP Inc. (OTC: AAPJ) is engaged in the provision of power, comfort and control systems for trailers, specialty vehicles, trucks, motor coaches and other applications.

The firm has its headquarters in Milford, Virginia and was incorporated in 1929 by Arthur Taubman. Prior to its name change in September 2011, the firm was known as Borneo Energy USA Inc. It operates as part of the motor vehicle and motor vehicle parts and supplies merchant wholesalers’ industry. The firm has three companies in its corporate family and serves consumers around the globe.

The company’sobjective is to create an organization which services and markets high tech products for demanding industries. It operates through the Independents and Worldpac, Carquest Canada, Southern Division and Northern Division segments.

The enterprise’s products include power transfer switches, electrical start assist devices, DC electrical systems, automatic computerized voltage disconnect systems, coolers, icemakers, freezers/refrigerators, sound attenuating foams, air purifiers, battery chargers and inverters, HVAC accessories and air conditioning/heating systems. It serves the special purpose vehicle, luxury motor coach, trucking, recreational vehicle, race car transporter, rescue, fire, medical and communication industries. The enterprise offers its products under the Vitrifrigo America, Domestic and AAP Inc. brands.

The company recently entered into a partnership agreement with North Star Developers LLC. This move enhances the company’s prospects for achieving its goals and adds to the company’s diverse and growing portfolio of businesses as well as its financial strength. The company is focused on solid business opportunities with attractive growth potential.

AAP Inc. (AAPJ), closed Wednesday's trading session at $0.0005, up 66.6667%, on 202,995,906 volume. The average volume for the last 3 months is 1.149M and the stock's 52-week low/high is $0.0001/$0.0043.

Moving iMage Technologies (MITQ)

StockEarnings, QualityStocks and BUYINS.NET reported earlier on Moving iMage Technologies (MITQ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Moving iMage Technologies Inc. (NYSE American: MITQ) is a digital cinema firm that is focused on designing, manufacturing, integrating, installing and distributing custom and standard designed equipment and other cinema products for cinema requirements.

The firm has its headquarters in Fountain Valley, California and was incorporated in September 2003 by Thomas Lipiec, Phil Rafnson, Glenn H. Sherman, David Richards, Jerry van de Rydt, Bevan Wright and Joe Delgado. It operates as part of the commercial and service industry machinery manufacturing industry in the United States. The firm serves consumers in Mexico, the U.S. and internationally.

The company’s services and products are focused on the needs related to the equipping, modernization and building of movie exhibition theatres.

The enterprise offers proprietary rack mount pedestals; assembled and in-house designed products to support alternative auditorium configurations and boothless theatre designs; automation systems for digital cinema applications; and assembled and in-house designed dimmers and lighting products. It also distributes cinema serves and projectors and provides demand controlled ventilation systems; premium sound systems and enclosures; and aisle lighting products, tablet arms, concession trays and tables, and cup holders for theaters. This is in addition to offering Cinergy, which enables an exhibitor to manage, monitor and store digital cinema log files in a centralized and secure location; and software solutions, including a cinema presence management and remote control system known as CineQC.

The firm was recently awarded a $1.6 million contract by Alamo Drafthouse Cinema to provide various cinema products to Alamo’s new Rhode Island location. This move not only brings in revenue to the firm but also helps extend its consumer reach to a new location, which will be good for the company’s growth.

Moving iMage Technologies (MITQ), closed Wednesday's trading session at $1, up 42.8571%, on 67,900,279 volume. The average volume for the last 3 months is 3,539 and the stock's 52-week low/high is $0.4201/$1.44.

Zeo ScientifiX (ZEOX)

We reported earlier on Zeo ScientifiX (ZEOX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Zeo ScientifiX Inc. (OTCQB: ZEOX) is a clinical-stage biopharmaceutical firm focused on developing biological therapeutics to help treat degenerative illnesses.

The firm has its headquarters in Fort Lauderdale, Florida and was incorporated in 2011, on August 9th by Maria Ines Mitrani, Albert Mitrani, and John Goodhew. Prior to its name change in March 2024, the firm was known as Organicell Regenerative Medicine Inc. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the globe.

The company is party to an agreement with Oklahoma State University to evaluate Zofin’s effectiveness in treating respiratory illnesses caused by virus infections of pandemic potential. It is also party to a research and development agreement with the Centers for Disease Control and Prevention to determine the anti-inflammatory and anti-infective effectiveness of Zofin in experimental models of influenza infection.

The enterprise’s lead product candidate is Zofin, an acellular biologic therapeutic derived from perinatal sources. This formulation is in Phase I/II clinical trials evaluating its effectiveness in treating chronic obstructive pulmonary disease, COVID-19, and knee osteoarthritis. It also offers Patient Pure X, an autologous blood-derived biologic technology that is placed in the body for regulating exosomes, which trigger the cascade of cellular reprogramming and tissue repair.

The firm recently changed its name to reflect its growth as it advances towards a future where innovative biologic therapeutics will redefine the standard of care for many important chronic illnesses and acquiring FDA approval for its proprietary therapeutics. This may benefit patients with various conditions while also generating value for its shareholders.

Zeo ScientifiX (ZEOX), closed Wednesday's trading session at $1.49, even for the day, on 106 volume. The average volume for the last 3 months is 2.311M and the stock's 52-week low/high is $0.80/$4.80.

HIVE Blockchain Technologies Ltd. (HIVE)

QualityStocks, InvestorPlace, MarketClub Analysis, MarketBeat, CryptoCurrencyWire, Zacks, StreetInsider, Early Bird, Marketbeat.com, StockMarketWatch, Stock Market Watch, Greenbackers, Hit and Run Candle Sticks, Barchart, smartOTC, StockOodles, StreetAuthority Daily, The Night Owl, The Online Investor, TopStockAnalysts, Wall Street Resources, WealthMakers and Schaeffer's reported earlier on HIVE Blockchain Technologies Ltd. (HIVE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

President Joe Biden has vetoed a measure aimed at overturning a contentious directive from the U.S. Securities and Exchange Commission (SEC) regarding the accounting practices for companies handling cryptocurrency assets.

In a letter addressed to the House of Reps and published on the White House website, President Biden stressed his administration’s commitment to protecting investors and consumers, stating that appropriate safeguards are essential to leveraging the opportunities and benefits of cryptocurrency innovation.

The measure in question sought to repeal the commission’s staff accounting bulletin, known as SAB 121, which has been a point of contention within the crypto sector. The House had previously passed the now vetoed measure with a 228–182 vote, primarily supported by Republicans but with the backing of 21 Democrats as well. Shortly thereafter, the Senate also approved the measure with a 60–38 vote, including support from several Democrats, notably Chuck Schumer, the Senate majority leader.

For a veto to be overturned, a two-thirds majority vote is required in both the House and Senate. Despite the bipartisan support, Biden had indicated his intention to veto the bill in a prior statement, arguing that restricting the commission’s ability to enforce a robust and effective financial regulatory structure for crypto could lead to significant financial instability and unpredictability in the market.

This isn’t the first instance where Biden has vetoed bipartisan measures. He previously vetoed a resolution aimed at overturning a joint employer regulation, which had also passed both chambers with bipartisan support.

The controversy surrounding SAB 121 stems from its implications for banks and other institutions that custody digital assets. Critics argue that it could hinder banks from safeguarding digital assets as it requires companies that custody crypto to list customer crypto holdings as liabilities on their statements of financial position.

The SEC maintains that the bulletin is just a staff guideline that is not legally binding and is meant to improve investor transparency. Last month, a SEC representative highlighted past failures of crypto companies where customers were left seeking legal recourse through bankruptcy courts; the official emphasized the importance of disclosures that provide a clear understanding of the risks taken by crypto custodians.

Biden’s veto has sparked discontent within the cryptocurrency community, particularly given the speculation that his administration has been making efforts to engage with the industry more positively.

Crypto Council CEO Sheila Warren expressed her disappointment, noting that publicly stated positions can be challenging to retract. Additionally, Representative Mike Flood voiced his frustration on social media, acknowledging the setback but reaffirming his belief in the enduring significance of crypto and digital assets in the future of the U.S.’s financial landscape.

Crypto industry actors such as HIVE Blockchain Technologies Ltd. (NASDAQ: HIVE) (TSX.V: HIVE) can only hope that Congress takes the initiative and passes legislation to not only oversee the industry but also foster growth so that the enforcement-first approach being taken by the SEC is brought to an end.

HIVE Blockchain Technologies Ltd. (HIVE), closed Wednesday's trading session at $2.85, up 2.518%, on 3,649,233 volume. The average volume for the last 3 months is 7.156M and the stock's 52-week low/high is $2.18/$6.84.

SNDL Inc. (SNDL)

Schaeffer's, StockEarnings, InvestorPlace, StocksEarning, QualityStocks, MarketBeat, Trades Of The Day, Daily Trade Alert, BUYINS.NET, Kiplinger Today, The Street, StreetInsider, The Online Investor, FreeRealTime, Early Bird, CannabisNewsWire, CNBC Breaking News, Investopedia, MarketClub Analysis, Prism MarketView, StockMarketWatch and MarketClub reported earlier on SNDL Inc. (SNDL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Could the reclassification of cannabis lead to significant reductions in energy consumption by commercial marijuana cultivators and overall improvement in the industry’s environmental impact?

It’s well-known that indoor marijuana cultivation facilities have a major environmental and energy footprint. This is largely due to the massive electricity consumption required for robust HVAC systems, horticultural lighting, and numerous fans and pumps needed to create optimal growing conditions.

Although the exact details of a post-scheduling cannabis industry in the United States are unknown, we can learn from the controlled-environment agriculture (CEA) industry about potential changes in cannabis growing, such as the adoption of less energy-intensive techniques.

Reclassification could unlock a variety of federal programs that are currently inaccessible to cannabis entities due to federal prohibition.

The Biden administration allocated billions for agricultural and clean-energy projects in 2022 through the Inflation Reduction Act. For instance, the U.S. Department of Agriculture (USDA) has, through loan guarantees and grants, helped domestic CEA enterprises install efficient and sustainable energy technologies. These include chillers, heat pumps, LED grow lights, clean-power generation and sophisticated HVAC systems.

The program works better for larger institutions due to the significant administrative effort associated with applying for USDA assistance.

Nonetheless, CEA companies of all sizes can obtain support navigating USDA grant and loan applications from a number of federal grant aid organizations. The IRS provides a 30% investment tax credit for marijuana companies that want to install renewable energy sources, such as solar panels, on their property.

Developers of cultivation facilities sometimes point to the high upfront costs as a primary deterrent to the installation of cutting-edge, energy-efficient machinery. Rescheduling could free operators from the restrictions imposed by Section 280E of the IRS, which levies greater taxes on corporations that handle plants than on conventional enterprises. This might free up funds, allowing numerous operators to modernize their spaces for increased energy efficiency.

As of right now, indoor facilities are not subject to any national codes; however, this could change in the future when the International Energy Conservation Code is updated. States that enforce clean-air vehicle requirements, such as California, may, in the meantime, implement more stringent regulations than those established by the federal government.

In the meanwhile, multistate cannabis companies will have to manage a complicated web of regulations.

The potential reclassification of cannabis presents a great opportunity to make the industry more environmentally sustainable. It’s imperative that marijuana businesses keep up with constantly changing federal regulations and proactively implement clean, energy-efficient technology.

Compared to outdoor farms or traditional greenhouses, indoor agriculture requires a lot more electricity per square foot yet permits year-round production regardless of the weather. In the event that cannabis becomes legally transferable across state lines, growers may decide to move from costly indoor models in the north to more affordable outdoor or greenhouse settings in the South and west.

Although this transition could take decades, shifting production to more naturally conducive areas would significantly lessen the industry’s overall environmental footprint.

As the anticipated regulatory change is still very much in flux, entities such as SNDL Inc. (NASDAQ: SNDL) are likely to observe and later decide how best to leverage the changed regulatory landscape in order to further optimize their operations.

SNDL Inc. (SNDL), closed Wednesday's trading session at $2.16, up 2.3697%, on 1,616,276 volume. The average volume for the last 3 months is 10.363M and the stock's 52-week low/high is $1.25/$2.93.

Coinbase Global Inc. (COIN)

Schaeffer's, InvestorPlace, The Street, MarketClub Analysis, QualityStocks, Prfmonline, Zacks, MarketBeat, Greenbackers, Early Bird, StockEarnings, Kiplinger Today, INO Market Report, Investopedia, SmallCapVoice, OTCPicks, The Online Investor, Ceocast News, The Wealth Report, CoolPennyStocks, HotOTC, InsiderTrades, Daily Trade Alert, StocksEarning, Trades Of The Day, StockEgg, Penny Invest, Stock Stars, Stock Rich, CryptoCurrencyWire, FreeRealTime, Top Pros' Top Picks, TradersPro, BestOtc, CNBC Breaking News, Top Gun, The Stock Psycho, Investors Underground, StockHotTips, HotShotStocks, BullRally, Wealth Daily, Energy and Capital, MadPennyStocks, BillionDollarClub, Jeff Bishop, Today's Financial News, Summa Money, StockRich, Smartmoneytrading, PennyStockVille, Stockpalooza, PennyTrader Publisher, Profit Confidential, bullseyeoptiontrading, PennyInvest, FeedBlitz, Cabot Wealth, AlphaShark Trading, Atomic Trades, Early Investing, Dawn Report, Blaque Capital Stocks, BloomMoney, Eagle Financial Publications, Dynamic Wealth Report, CRWEWallStreet, Stock Analyzer, wyatt research newsletter, WiseAlerts, wealthmintrplus, Wealth Whisperer, TradingPub, Trading with Larry Benedict, TipRanks, StockMister, Penny Stock Finder, Stock Fortune Teller, Green Chip Stocks, Standout Stocks, Round Up the Bulls, Pennybuster, Penny Stock Rumble, AllPennyStocks, Momentum Traders, MicrocapVoice, Louis Navellier, InvestorsUnderground and Stock Traders Chat reported earlier on Coinbase Global Inc. (COIN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Since its inception in 2012, Coinbase Global Inc. (NASDAQ: COIN) has been a forerunner in the digital asset arena. However, the largest cryptocurrency exchange in the United States is facing a significant trading decline as the crypto market matures, a major blow to investors. Experts allude to this shift in reducing market volatility, which is impacting Coinbase’s main source of revenue.

The digital assets market has undergone several transformations over the years, including direct listing on the NASDAQ in April 2021 and a reduction in the average volatility from 79% in 2021 to 57% in 2024. This reduction is largely due to the introduction of factors such as spot Bitcoin ETFs, which have led to the resurgence of institutional investors in the market.

Consequently, Coinbase’s consumer trading volume plummeted from  $177 billion in the fourth quarter of 2021 to only $56 billion in the first quarter of 2024, putting much pressure on its financial stability. As you know, the company’s business model is centered on transaction fees charged on trades, thus making trading revenues an important part of its financial health.

While the reduction in market volatility is good news for traders and overall market stability, it has resulted in Coinbase facing fewer trading opportunities and low transaction fees. As a way of dealing with the changing market dynamics, the popular cryptocurrency exchange is actively diversifying its revenue streams beyond traditional trading. The company has introduced new products, such as non-fungible tokens (NFTs). In first quarter 2024, Coinbase made one-third of its sales from stablecoin revenue and blockchain services.

What’s more, Coinbase is focusing on global expansion through the Go Broad, Go Deep expansion strategy. The aim is to strengthen the company’s foundation in existing markets and tap into emerging markets with significant growth potential. In fact, the company expanded from being oly in the United States to operating in 38 countries. According to company officials, they believe the company will grow since 80% of the global crypto trading market occurs internationally.

Additionally, Coinbase has expanded its blockchain technological services by offering different kinds of products, tools and services to help businesses and developers. This has helped the company offset most of its losses from trading revenues.

Thus, despite Coinbase’s trading revenue challenges as a result of the maturing crypto market, the company’s future is looking up. With its plan to continue to diversify and become innovative, Coinbase can continue to be a leader in the digital asset space and navigate through the evolving landscape.

Coinbase Global Inc. (COIN), closed Wednesday's trading session at $251.4, up 2.9484%, on 9,383,502 volume. The average volume for the last 3 months is 12.5M and the stock's 52-week low/high is $46.43/$283.48.

Newmont Corporation (NEM)

MarketClub Analysis, InvestorPlace, The Street, Schaeffer's, Kiplinger Today, MarketBeat, StocksEarning, Investopedia, The Online Investor, INO.com Market Report, Barchart, StreetAuthority Daily, Top Pros' Top Picks, Daily Trade Alert, QualityStocks, TopStockAnalysts, StreetInsider, Louis Navellier, Streetwise Reports, Daily Wealth, SmarTrend Newsletters, Zacks, Money Morning, TradingMarkets, Uncommon Wisdom, PROFIT CONFIDENTIAL, Marketbeat.com, Wealth Daily, The Growth Stock Wire, Trades Of The Day, TheStockAdvisor, The Wealth Report, Lebed.biz, StockEarnings, ProfitableTrading, Wall Street Grand, Trading Tips, Cabot Wealth, Investing Signal, TheStockAdvisors, Market Intelligence Center Alert, Dividend Opportunities, The Best Newsletters, DividendStocks, All about trends, National Inflation Association, InvestorIntel, Trading Markets, MiningNewsWire, InvestmentHouse, AllPennyStocks, Energy and Capital, Market FN, Wyatt Investment Research, Money Wealth Matters, Early Bird, Money and Markets, Darwin Investing Network, Stockhouse, Daily Markets, TradingAuthority Daily, OTC Stock Pick, InvestorsObserver Team, Wall Street Daily, Investment House, Buttonwood Research, Street Insider, Investors Alley, Wall Street Greek, Dynamic Wealth Report, The Tycoon Report, Investiv, Eagle Financial Publications, StreetAlerts, Investing Futures, Trading with Larry Benedict, Wealth Insider Alert, Investor News, Trading Concepts, Trader Jack, MarketWatch, Short Term Wealth, FNNO Newsletters, StockTwits, Investment U, FreeRealTime, 24/7 Trader, FutureMoneyTrends.com, TipRanks, The Stock Enthusiast, Daily Profit, Market Authority, Investing Daily, Insider Wealth Alert, INO Market Report, Global Equity Report, Candle Stick Forum, CNBC Breaking News, CrushTheStreet.com, Global Equity Alert, equities Canada, Earnings360, ChartAdvisor, Total Wealth, Normandy Investment Research, SmallCap Network, Super Stock Picker, The Motley Fool, The Street Report, Seeking Alpha, The Weekly Options Trader, Rick Saddler, Trade of the Week, UndiscoveredEquities, Vantage Wire, VectorVest, Wall Street Window, Weekly Wizards, The Wall Street Transcript, OTCPicks, Investor Update, Investors Insights, Jim Cramer, Leeb's Market Forecast, MarketClub, Small Cap Firm, One Hot Stock, Investor Guide, Penny Detectives, Penny Stock Buzz, PennyStockProphet, Power Profit Trades, Profitable Trader Authority, Profits Run and Navellier Growth reported earlier on Newmont Corporation (NEM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

In its latest earnings call, Costco announced that total growth recorded in e-commerce sales in the third quarter was led by silver and gold bullion, appliances and gift cards. Gary Millerchip, the company’s chief financial officer, revealed that they recorded a more than 20% increase in online sales in the last quarter.

The company’s latest earnings exceed Wall Street’s expectations, noting in its statement that their members flocked to their warehouses looking for quality goods at affordable prices.

In December 2023, the company revealed that it was selling gold bars worth more than $100 million in a quarter, noting that sometimes the goods would run out in a few hours.

Investigators at Wells Fargo also estimate that about a month ago, the company may have raked in $100 to $200 million in monthly revenue from the products they launched late last summer. These levels, despite being high, are a drop in the bucket for Costco, which recorded net sales totaling $57 billion in the last quarter.

Analysts believe that margins on the company’s silver and gold offerings are probably low. Despite this, the gold rush represents a sign that consumers regard these precious metals as a safe investment, particularly during uncertain times.

Apex Financial Services’ founder Lee Baker stated that anxiety driven by geopolitical tensions and inflation among other issues was making consumers buy gold out of fear. Baker, who is also AARP Georgia’s president, then noted that this had driven the price of gold to record highs, with the metal hitting $2,450 an ounce last month. This is a significant increase from the $2,100 recorded at the start of March.

Advantages of investing in gold include diversification of one’s portfolio, which can help increase returns while also managing risk in the long run. Additionally, precious metals such as silver and gold are regarded as safe-haven assets that hedge against stock market volatility and inflation. It is important for investors to note that while these metals have various advantages, they also have their disadvantages. For instance, precious metals, unlike other assets, do not produce any cash flow through interest or yields.

Those who would like to purchase these metals should monitor the metal prices regularly in order to know when the time has come to sell them. Furthermore, those who would like to store silver or gold in their homes may incur additional costs. This includes investing in a secure place to store the metals such as a safe, as well as insuring them.

This increasing purchase of gold bars by laypeople bodes well for extraction companies such as Newmont Corporation (NYSE: NEM) since they are assured of growing demand not just from major end-buyers, such as central banks, but also retail chains bringing precious metals closer to consumers.

Newmont Corporation (NEM), closed Wednesday's trading session at $41.1, up 1.4064%, on 6,110,847 volume. The average volume for the last 3 months is 91.86M and the stock's 52-week low/high is $29.42/$45.92.

Nikola Corporation (NKLA)

Green Car Stocks, Schaeffer's, InvestorPlace, StockEarnings, QualityStocks, MarketClub Analysis, StocksEarning, MarketBeat, The Street, Kiplinger Today, Early Bird, Trades Of The Day, StreetInsider, Daily Trade Alert, The Online Investor, Zacks, GreenCarStocks, Cabot Wealth, Louis Navellier, Investopedia, Wealth Insider Alert, CNBC Breaking News, MarketTamer, INO Market Report, InvestorsUnderground, Earnings360, BillionDollarClub, Daily Profit, The Wealth Report, Daily Wealth, StockMarketWatch, Prism MarketView, Green Energy Stocks, Outsider Club, AllPennyStocks and DividendStocks reported earlier on Nikola Corporation (NKLA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Micro-electric vehicles could be the smoking gun that finally breaks the dominance of SUVs (sports utility vehicles) on American roads. Unlike consumers in the European Union, American drivers have repeatedly shown that they prefer larger vehicles, such as SUVs and pickup trucks, over smaller cars, making them less likely to purchase regular-sized electric cars.

The International Energy Agency (IEA) estimates that sports utility vehicles accounted for a whopping 50% of global vehicle sales last year. Demand for SUVs and similar large vehicles is on the rise, and the IEA notes that the transition to “larger and heavier” vehicles is one of the early 21st century’s most-defining automotive trends.

Automakers in the United States began churning out larger cars to circumvent certain emissions standards, and few of them have taken any steps to develop a small electric car in recent years. As a result, American drivers only have access to electric sedans and pickup trucks, with the majority still opting to purchase internal combustion engine (ICE) SUVs.

Established automakers such as Ford have tried to work around this issue by developing larger electric vehicles, including the F-150 Lightning, which fulfill the desire for a large vehicle and produce zero tailpipe emissions. Tesla’s Cybertruck as well as the Rivian R1T are also attempts to attract more Americans to the EV camp with a large electric truck. Unfortunately, the upfront costs involved mean only a small percentage of the American market can afford to purchase an electric pickup truck.

However, tiny electric cars have the potential to bridge the popularity gap between the nascent electric vehicle industry and SUVs. Chinese automakers have already achieved a lot of success with tiny EVs over the past decade, especially in dense Chinese cities where smaller vehicles offer better maneuverability. Smaller electric cars also tend to be cheaper, making them more accessible to consumers with budget constraints.

Challenging SUVs’ dominance in the global market will still prove to be a significant hurdle due to their market popularity and the benefits they offer manufacturers. University of Birmingham professor of business economics David Bailey notes that the popularity of the sports utility vehicle isn’t a fluke but the result of several different factors.

Consumer demand for increased cabin space as well as regulations covering factors such as emissions control systems and airbags have made it more economically feasible for carmakers to develop larger cars. These pressures would ultimately increase the costs involved in manufacturing smaller electric vehicles, the professor states.

It is now incumbent upon other electric vehicle makers such as Nikola Corporation (NASDAQ: NKLA) to come up with smaller EV models that will appeal to consumers who are concerned about the current cost of larger models.

Nikola Corporation (NKLA), closed Wednesday's trading session at $0.5351, up 6.3183%, on 53,257,880 volume. The average volume for the last 3 months is 7.936M and the stock's 52-week low/high is $0.4921/$3.71.

Aurora Cannabis Inc. (ACB)

InvestorPlace, Schaeffer's, MarketClub Analysis, StocksEarning, MarketBeat, The Street, QualityStocks, StockEarnings, Trades Of The Day, Daily Trade Alert, StreetInsider, The Online Investor, Wealth Insider Alert, Market Intelligence Center Alert, Kiplinger Today, StockMarketWatch, CFN Media Group, Investopedia, Stock Up Featured, Profit Trends, BUYINS.NET, Jim Cramer, BlackSwanAlert, The Rich Investor, StreetAuthority Daily, Early Bird, Cannabis Financial Network News, CNBC Breaking News, Inside Trading, CannabisNewsWire, Daily Profit, Investors Alley, Investors Underground, Market Intelligence Center, Outsider Club, Zacks, Technology Profits Daily, The Wealth Report, TheTradingReport, Top Pros' Top Picks, Tradespoon, Wall Street Window and Money and Markets reported earlier on Aurora Cannabis Inc. (ACB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The use of machine learning in indoor marijuana cultivation facilities is increasing, with growers using advanced cameras and sensors to sound alarms on threats such as disease or pests, decrease labor costs linked to different level growing tasks and maintain optimal conditions for plant growth.

The primary reasons why marijuana and other indoor cultivation companies are making use of artificial intelligence (AI) or machine learning tech in their facilities include the following:

  • Consistency is needed in indoor growing facilities, and artificial intelligence can deliver this.
  • Resources such as energy and labor that are required to cultivate marijuana indoors are costly; consequently, tech powered by AI can help decrease those costs.

At the moment, artificial intelligence for indoor cultivation is almost able to monitor and call attention to invisible things such as changes in growth rate in plants. Once consistency is achieved in the future, artificial intelligence may be able to improve rates of growth.

For 22Red’s Head of cultivation, Stephen Hess, artificial intelligence has eliminated most of the logistical and manual work involved in growing marijuana. This has afforded the Arizona-based marijuana company more time to focus on other tasks while also saving on labor costs.

The company implemented the Spyder technology, developed by Neatleaf, at its facility. The technology is comprised of sensors that track data such as humidity, temperature and leaf color at different times of the day for microclimates or individual plants in the facility. This technology then evaluates data collected to detect signs or patterns of stress and presents its findings on a dashboard, complete with light maps, heat maps and charts, for the company to study.

According to Hess, the technology’s recommendations are more accurate because it makes calculations based on what the system has monitored. Before 22Red used this technology, it had to use handheld sensors to collect the same data. In addition, thousands of dollars in salaries were spent annually for employees who did this work.

Now with this tech, the company only pays $600 in subscription fees to Neatleaf along with another $600 monthly for assessments.

It should be noted, however,  that not all facilities can accommodate this Neatleaf system. Currently, Spyder cannot collect data from areas that are blocked or too low. This includes vertical growing facilities or facilities whose pillars block the sensors.

22Red isn’t the only company making use of advanced technology in their facilities either. Other companies, such as Jushi Holdings, use equipment with machine- learning to control their building-management system. This has allowed the Florida-based company to efficiently gather and analyze data and produce marijuana more sustainably while also decreasing energy costs.

As more AI solutions become available, a time may come when major cannabis companies such as Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) largely rely on these systems to grow higher-quality marijuana to address the needs of their customers.

Aurora Cannabis Inc. (ACB), closed Wednesday's trading session at $6.09, up 3.3956%, on 1,063,255 volume. The average volume for the last 3 months is 293 and the stock's 52-week low/high is $2.84/$11.50.

Lelantos Holdings Inc. (LNTO)

QualityStocks and Green Energy Stocks reported earlier on Lelantos Holdings Inc. (LNTO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lelantos Holdings (OTC: LNTO) today announced that its subsidiary, Eco Management Systems, has reached significant sales milestones since the company executed a memorandum of understanding (“MOU”) to acquire Eco, a licensed and full-service commercial and residential solar contractor, on Feb. 13, 2024. Since this date, and largely due to the efforts of Lelantos’ executive team, Eco has increased its sales volume and signed a 264,650 total watts contract with a value of $1,040,579.56. These projects are in various stages of development, from permitting and preconstruction activities all the way through to procurement and initiating installation. “Lelantos recognized the potential that Eco Management had and immediately got to work on implementing programs that have had tremendous success with previous companies I have led,” said Sean Land, president of business development for Lelantos. “Eco had the infrastructure in place already to dramatically increase sales. By working hand-in-hand with their team, we enhanced what they already had in place and have positioned the company on an upward trajectory for the near and long-term future.”

To view the full press release, visit https://ibn.fm/wKq43

About Lelantos Holdings

Founded in the spirit of “Solution Hunting,” Lelantos Holdings’ innovative business structure is purpose-built to acquire or joint venture with established entities in strategic market sectors. With a focus on sustainable energy, Lelantos Holdings has a mission of being at the forefront of innovation in a dynamic industry, and the goal of operating as a vertically integrated entity to reduce overhead and increase service offerings. Although Lelantos is a new entity, the company’s overall vision has been collectively developed by a seasoned management team over the past decade to culminate its current operations, foster innovation and advance technological developments.

Lelantos Holdings Inc. (LNTO), closed Wednesday's trading session at $0.26, even for the day. The average volume for the last 3 months is 8.584M and the stock's 52-week low/high is $0.105/$2.75.

Sharps Technology Inc. (STSS)

RedChip, StockWireNews, StockStreetWire, Small Cap Firm, MarketClub Analysis, Fierce Analyst, QualityStocks, ProTrader, AwesomeStocks, Early Bird and 247 Market News reported earlier on Sharps Technology Inc. (STSS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sharps Technology (NASDAQ: STSS), a medical device company, has announced a Reg A+ warrant inducement offering. The offering, which was announced earlier this week, is estimated to reach approximately $2.2 million. The company has filed the required forms for the offering with the U.S. Security Exchange Commission (“SEC”). According to the announcement, Aegis Capital Corp. is acting as the exclusive placement agent for the offering. Aegis Capital Corp. has been in the wealth-management and investment-banking business for four decades.

To view more information, visit https://ibn.fm/4ZxZd

About Sharps Technology Inc.

Sharps Technology, a medical device company, engages in the design, research and development, manufacturing and commercialization of safety syringe  products in the United States. The company provides safety syringe products comprising Securgard, Sologard and Sharps Provensa that are ultra-low waste syringes for passive, safety and reuse prevention features. Sharps Technology also develops prefillable syringe systems. The company was incorporated in 2017 and is based in Melville, New York. For more information about the company, visit www.Sharpstechnology.com.

Sharps Technology Inc. (STSS), closed Wednesday's trading session at $0.3361, off by 8.4196%, on 3,865,989 volume. The average volume for the last 3 months is 187,628 and the stock's 52-week low/high is $0.173901/$1.05.

Bluejay Diagnostics Inc. (BJDX)

QualityStocks, Trades Of The Day, MarketClub Analysis, MarketBeat and 247 Market News reported earlier on Bluejay Diagnostics Inc. (BJDX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bluejay (NASDAQ: BJDX) is a medical diagnostics company that offers the Symphony technology platform, Symphony Cartridge and tests and testing devices for the diagnosis of allergic conjunctivitis and monitoring of disease progression in critical care settings. Aegis Capital Corp. announced that it acted as exclusive placement agent on a ~$2.2 million private placement for Bluejay Diagnostics.

To view the Form 8-K filing, visit https://ibn.fm/3xAyc

About Bluejay Diagnostics Inc.

Bluejay operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts. For more information about the company, visit www.Bluejaydx.com.

Bluejay Diagnostics Inc. (BJDX), closed Wednesday's trading session at $0.562, off by 13.711%, on 1,716,602 volume. The average volume for the last 3 months is 548,125 and the stock's 52-week low/high is $0.39/$13.9799.

The QualityStocks Company Corner

Annovis Bio Inc. (NYSE: ANVS)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings Inc. (NYSE: ANVS).

SOBRsafe (NASDAQ: SOBR), a provider of next-generation, transdermal alcohol-detection solutions, has signed hardware/software agreements with two prominent recovery services: Hired Power and The Firm. According to the announcement, both companies have already made SOBRsure(TM) device purchases. In addition, following the anticipated launch of SOBRsafe's enterprise client-management software, which offers passive, 24/7 capabilities and discrete, noninvasive client experiences, the two companies plan on replacing breathalyzers for use in remote-client monitoring. A leader in professionalized transition services, California-based Hired Power works with thousands of treatment centers, professionals and clients to help individuals achieve and maintain successful recovery and fulfillment. Tennessee-based The Firm has built a reputation for providing lifesaving solutions, such as family education, intervention, long-term case management and monitoring services, for those battling addiction.

To view the full press release, visit https://ibn.fm/LsWfc

Annovis Bio Inc. (NYSE: ANVS) is a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD). Annovis Bio stands out by developing a drug that targets multiple neurotoxic proteins simultaneously, aiming to restore axonal and synaptic activity. This innovative approach aims to treat memory loss and dementia associated with AD and body and brain dysfunction associated with PD, making Annovis a unique player in the neurodegeneration space.

Lead Drug Candidate: Buntanetap

Buntanetap (formerly Posiphen) targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins, including amyloid beta, tau, alpha-synuclein, and TDP43. This multifaceted inhibition improves synaptic transmission and axonal transport, reduces neuroinflammation, and protects nerve cells from dying. Unlike monoclonal antibody therapies, Buntanetap is an orally available small molecule capable of inhibiting multiple neurotoxic proteins at once, positioning it as a comprehensive solution for neurodegenerative diseases.

In a recent Phase II/III Alzheimer’s study, Buntanetap demonstrated statistically significant efficacy. Patients with early AD showed a significantly higher rate of improvement in ADAS-Cog 11 scores across all treatment doses compared to placebo, with a -3.3 point improvement compared to -0.3 for placebo (p < 0.01). Plasma Tau protein levels also reduced, consistent with previous Phase II biomarker data, further validating Buntanetap’s mechanism of action.

Similarly, in the Phase III study of Buntanetap in patients with early Parkinson’s disease, significant advancements were observed. Topline data results are anticipated in June 2024. Preliminary findings indicate promising results in improving cognitive and motor function, underscoring Buntanetap’s potential as a transformative therapy for Parkinson’s disease.

Market Opportunity

The aging population presents a significant market opportunity, with nearly 7 million Americans currently suffering from Alzheimer’s Disease (AD), a figure projected to rise to almost 13 million by 2050 (Alzheimer’s Association) (Republican Policy Committee). Additionally, approximately 1.2 million people in the U.S. have Parkinson’s Disease (SingleCare).

The economic burden of Alzheimer’s is immense, with care costs expected to reach $360 billion in 2024 and escalate to nearly $1 trillion annually by 2050. The need for effective, comprehensive treatments like Buntanetap is more critical than ever.

Company Highlights

  • Innovative Therapeutic Approach: Annovis Bio uniquely targets multiple neurotoxic proteins, aiming to restore nerve cell health and improve cognitive and motor function in AD and PD patients.
  • Robust Clinical Data: Phase II/III studies show significant improvements in cognitive function and biomarker levels in early AD patients.
  • Groundbreaking Clinical Insights: Preliminary results from Phase II studies indicate significant improvements in motor functions and speed in patients with Parkinson’s Disease (PD).
  • Upcoming Phase III Trials: Plans are underway for an 18-month Phase III trial focusing on biomarker-positive early AD patients, designed to further validate Buntanetap’s disease-modifying potential.
  • Capital Efficiency: Annovis Bio is capital-efficient, with zero debt and multiple global patents extending into the 2040s.

Management Team

Maria L. Maccecchini, Ph.D., Founder, President, CEO, and Executive Board Member, founded Annovis Bio in May 2008 with the mission to develop better therapeutics for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. She has previously been a partner and director at two angel groups, Robin Hood Ventures and MidAtlantic Angel Group, and founded Symphony Pharmaceuticals/Annovis, which was sold to Transgenomic in 2001. Her extensive experience includes roles such as General Manager at Bachem Bioscience and Head of Molecular Biology at Mallinckrodt. Dr. Maccecchini holds a Ph.D. in biochemistry from the Biocenter of Basel, with postdoctoral work at Caltech and the Roche Institute of Immunology.

Cheng Fang, Ph.D., Senior VP of Research and Development, is an accomplished neuroscientist with two decades of experience in neurodegenerative diseases. She has a successful track record of scientific publications and contributions, coupled with extensive pre-clinical and clinical development experience. Dr. Fang has been instrumental in advancing the understanding of neurodegenerative disease mechanisms and developing therapeutic strategies.

Michael Christie, Ph.D., VP of Process Chemistry, has over 40 years of experience in the pharmaceutical industry, focusing on process chemistry R&D, pilot plant production, and GMP operations. He has held senior management positions at companies such as SmithKline, Rhodia, Teva, and Cephalon, and founded a contract process R&D service company, which was later acquired by ChiRex. Dr. Christie is co-author or co-inventor on several publications and patents. He earned his BS in chemistry from the University of Michigan and his doctorate from MIT.

Melissa Gaines, Senior VP of Clinical Operations, is an accomplished clinical research professional with over 20 years of experience across academia, contract research organizations, and pharmaceutical companies. She has proven abilities in monitoring and managing Phase I to IV clinical trials, specializing in CNS disorders and extending to a broad range of therapeutic indications. Her CNS experience spans from small Phase I and II studies to large global Phase III trials in Alzheimer’s disease, Parkinson’s disease, sleep disorders, and various psychiatric diseases in both adult and pediatric populations. In her current role, she oversees and supports all clinical project activities, driving operational success and ensuring high-quality clinical outcomes.

Learn more about the Annovis Bio team on LinkedIn.

Annovis Bio Inc. (NYSE: ANVS), closed Wednesday's trading session at $6.73, up 1.8154%, on 288,946 volume. The average volume for the last 3 months is 3,414 and the stock's 52-week low/high is $4.79/$22.49.

Recent News

Astrotech Corp. (NASDAQ: ASTC)

The QualityStocks Daily Newsletter would like to spotlight Astrotech Corp. (NASDAQ: ASTC).

Clene announced significant updates to their NIH-funded Accelerating Access to Critical Therapies Expanded Access Program (ACT-EAP) for CNM-Au8(R) compassionate use in amyotrophic lateral sclerosis ("ALS")

Clene has optimized its manufacturing, operational, and personnel processes to expand the program's capacity to accommodate up to 180 participants

The ACT-EAP, a collaboration among Clene, Columbia University, and Synapticure, was funded by the Accelerating Access to Critical Therapies for ALS Act (ACT for ALS), signed into law by Congress and President Biden in December 2021

Clene (NASDAQ: CLNN) and its subsidiary, Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company dedicated to improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases such as ALS and multiple sclerosis ("MS"), recently announced significant updates to their ACT-EAP for CNM-Au8 compassionate use in ALS (https://ibn.fm/aBWxl).

Astrotech Corp. (NASDAQ: ASTC) is an instrumentation company that designs, manufactures and commercializes solutions. Its solutions include mass spectrometry, process controls, chemical detectors and medical disease detection.

The company was established in 1984 and, prior to 2009, was known as SPACEHAB Inc., a NASA contractor offering technology originally developed for NASA to monitor air quality on the International Space Station. When the Space Shuttle program ended, the company focused on its satellite processing and mass spectrometer instrumentation units and adopted the Astrotech name.

In 2014, Astrotech sold its satellite subsidiary to focus on its Astrotech Technology Inc. (ATi) mass spectrometry solutions, which offer a number of advantages over competing platforms. Notably, Astrotech’s ATi technology is ruggedized, rapid, simple to use and customizable, with hands-free calibration and tuning.

Between 2016 and 2019, the company secured U.S. patents for its technology and achieved European Union (ECAC) certification for the TRACER 1000™, the world’s first mass-spec Explosives Trace Detector (ETD) used in airports worldwide. Astrotech continues to innovate and add to its suite of products, including AgLAB-1000, a process control system, and the BreathTest 1000, a disease detection solution.

Astrotech is headquartered in Austin, Texas.

Subsidiaries

Astrotech Technologies Inc.

Astrotech Technologies Inc. (ATi) owns and licenses the platform mass spectrometry technology originally developed by 1st Detect. This technology is designed to be less expensive, smaller and easier to use than traditional mass spectrometers.

Unlike other technologies, ATi works under high vacuum, which eliminates competing molecules, yielding higher resolution and fewer false alarms. The company’s intellectual property includes 18 granted patents, along with extensive trade secrets.

ATi exclusively licenses the Astrotech Mass Spectrometer Technology to the three wholly owned subsidiaries of Astrotech.

1st Detect Corp.

1st Detect Corp. developed the TRACER 1000, the world’s first mass spectrometry-based explosives and narcotics trace detector. 1st Detect ETDs were developed for use at airports, cargo facilities and other secured locations and borders worldwide.

1st Detect’s commercial sales of the TRACER 1000 ETD, consumables and recurring maintenance services brought in $750,000 in total revenue during the fiscal year ended June 30, 2023. The Astrotech subsidiary recently secured two orders for a total of 24 Tracer 1000 units from two Romanian security and telecommunications companies, to be delivered during calendar 2023.

AgLAB Inc.

AgLAB Inc. is developing a series of mass spectrometers for use in the hemp and cannabis market, with an initial focus on optimizing yields in the distillation processes.

AgLAB, which uses the company’s proprietary AgLAB 1000-D2™ mass spectrometer, has been proven to improve distillation oil yields and bottom-line profits for hemp and cannabis producers. During field trials, AgLAB was able to improve ending-weight yields by an average of 24%.

BreathTech Corp.

BreathTech is developing the BreathTest-1000™, a breath analysis tool to screen for volatile organic compound (“VOC”) metabolites found in a person’s breath that could indicate they may have a compromised condition including but not limited to a bacterial or viral infection. The company believes that new tools to aid in the battle against COVID-19 and other diseases remain of the utmost importance to help more quickly identify that an infection may be present.

Market Opportunity

A report by Mordor Intelligence, a research and advisory firm, put the global mass spectrometry market at $6.37 billion in 2023. The market is forecast to grow to $8.63 billion by 2028, achieving a CAGR of 6.25% during the forecast period.

One of the major driving factors for the growth of the mass spectrometry market is technological advancements in mass spectrometer devices, the report states. Key market players are continuously working toward advancing their existing products and launching innovative and advanced mass spectrometer devices.

Another major factor that is expected to boost market growth is increasing research and development expenditure by both government and private entities, according to the report. Mass spectrometry devices are also being used in the detection and analysis of COVID-19 and other disease samples, which may have a positive impact on the market.

Management Team

The Astrotech leadership team includes management executives, as well as industry and technology experts. The company continues to actively expand its talent pool to meet evolving demands.

Thomas B. Pickens III is Chairman, CEO and Chief Technology Officer of Astrotech Corp. He also serves as CEO of Astrotech subsidiaries ATi, 1st Detect, AgLAB Inc. and BreathTech Corp. Previously, he was the founder and president of Beta Computer Systems Inc. and T.B. Pickens & Co. He was founder and general partner of Grace Pickens Acquisition Partners L.P and managing partner of Sumpter Partners. He also served as CEO of Catalyst Energy Corporation and United Thermal Corporation and as president of Golden Bear Corp., United Hydro Inc. and Slate Creek Corp. He received a B.A. in Economics, Computer Science and Engineering from Southern Methodist University.

Jaime Hinojosa, CPA, is CFO at Astrotech Corp. He joined the company in 2015 and has served as its Corporate Controller since 2019. His previous roles with the company include Director of Finance, from 2017 to 2019, and Assistant Controller, from 2015 to 2017. Prior to joining Astrotech, Mr. Hinojosa worked as an Accounting Manager for O’Reilly Auto Parts and gained public accounting experience as an Audit Manager at Burton McCumber & Cortez LLP.

Astrotech Corp. (NASDAQ: ASTC), closed Wednesday's trading session at $9.35, even for the day, on 301 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $22.49/$.

Recent News

Clene Inc. (NASDAQ: CLNN)

The QualityStocks Daily Newsletter would like to spotlight Clene Inc. (NASDAQ: CLNN).

Golden Triangle Ventures (OTC: GTVH) ("GTV") today announced the successful completion of its acquisition of Cargo Management Group, a reputable and longstanding shipping, logistics and trucking operation, from TK Zarro, LLC. The acquisition marks a significant milestone in GTV's expansion efforts, as well as enhancing its operational capabilities within its Lavish Entertainment division and providing a full suite of in-house logistics capabilities for other company operations. Cargo Management Group reported nearly $3 million in revenue for 2023 and brings a robust portfolio of contracts with industry leaders such as JB Hunt, CH Robinson, Coyote Logistics, and Echo Logistics. "The acquisition of Cargo Management Group is a transformative step for GTV. This deal provides a scalable business model that will support both Lavish Entertainment and the development of our future flagship project, Destino Ranch," said Steffan Dalsgaard, CEO of Golden Triangle Ventures. "This business, its income, and our recently completed renegotiations on our outstanding note will dramatically impact our balance in a positive manner. Additionally, this helps move GTV toward its goal of becoming a highly profitable company with minimal to zero debt and a diverse asset portfolio."

To view the full press release, visit https://ibn.fm/nxKg8

Clene Inc. (NASDAQ: CLNN) is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple sclerosis (MS).

Its lead drug candidate is CNM-Au8®, an oral suspension developed to restore neuronal health and function by increasing energy production and utilization by driving critical cellular energy producing reactions that enable neuroprotection and remyelination to increase neuronal and glial resilience to disease-relevant stressors. CNM-Au8 is being studied in various clinical trials, including the Harvard/MGH Healey ALS Platform clinical trial for patients with ALS; RESCUE-ALS, a completed proof-of-concept clinical trial in patients with early symptomatic ALS; the REPAIR trials, completed target engagement clinical trials showing brain energy metabolite change with CNM-Au8; and a completed MS clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing MS. The company also has a nanotherapeutic platform of drug discovery.

CNM-Au8

CNM-Au8, Clene’s lead asset, is a highly concentrated aqueous suspension of catalytically active, clean-surfaced, faceted gold nanocrystals. Multiple pathogenic insults contribute to neuronal death. Mitochondrial dysfunction and NAD+ decline is a common final pathway in neurodegeneration, with NAD+ as a critical determinant of cell survival and function. CNM-Au8’s catalytic mechanisms target the energetic deficits, oxidative stress and accumulation of misfolded proteins that are common to many neurodegenerative diseases.

The unique catalytic mechanism of action of CNM-Au8 is hypothesized to act as a neuroprotective and remyelinating therapy in neurodegenerative disease states in order to: (1) drive, support and maintain beneficial metabolic and energetic cellular reactions within diseased, stressed and/or damaged cells, (2) directly catalyze the reduction of harmful, reactive oxygen species (“ROS”) and (3) promote protein homeostasis via activation of the heat shock factor-1 pathway, recognized to dampen the cytotoxicity caused by misfolded and denatured proteins, which are known to occur ubiquitously in neurodegenerative diseases.

CNM-Au8 is used in combination with other agents, has no known drug-drug interactions, and is designed to improve function and survival. The clinical effects of both function and survival were seen in its clinical ALS trials, as earlier announced.

More than 500 estimated years of collective exposure across ALS, MS, and Parkinson’s disease participants in CNM-Au8 clinical trials and Expanded Access Protocol (compassionate use) programs have been recorded without any observed safety signals.

CNM-Au8 is a federally registered trademark of Clene Inc. Clene, based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland, began in 2013.

Market Opportunity

ALS is the most prevalent adult-onset progressive motor neuron disease, affecting approximately 30,000 people in the U.S. and an estimated 500,000 people worldwide, with a life expectancy of typically three to five years. Clene estimates that global ALS treatment sales will be greater than $1 billion annually within the coming few years. Additional treatments affecting daily function and survival remain the market need.

Additionally, there are more than 2 million MS patients globally, and Clene estimates the market size to be worth more than $23 billion annually. While the MS community has been successful at limiting relapses, non-relapsing MS patients continue to clinically deteriorate even while receiving effective immunomodulatory disease-modifying therapies (“DMTs”). A critical unmet medical need remains for therapeutic interventions that protect neuronal function and myelin health independent of immunomodulation to address progression independent of relapse activity.

Management Team

Robert Etherington is President, Director and CEO of Clene. He has more than 30 years of sales, marketing and leadership experience in the pharmaceutical industry. Prior to joining Clene, he worked at Actelion Pharmaceuticals, the largest biopharma company in the European Union prior to its acquisition by Johnson & Johnson in 2017, where he led that company’s U.S. commercial operations. He began his pharmaceutical sales and marketing career at Parke-Davis, a division of Pfizer, where he rose to the position of Team Leader overseeing the drug Lipitor.

Mark Mortenson is Chief Science Officer at Clene. He is co-inventor of the technology platform developed to produce the company’s therapeutics. He is the inventor or co-inventor on 32 other U.S. patents and hundreds of corresponding international patents. He is a former chief patent counsel responsible for 5,500 U.S. and international patents and patent applications. He holds bachelor’s degrees in physics and ceramic engineering from Alfred University, a master’s degree in materials science from Penn State University and a J.D. from George Washington University.

Benjamin Greenberg, M.D., MHS, FAAN, is Head of Medical at Clene. He is an internationally recognized expert in disorders of the central nervous system. He is currently professor of neurology and Vice Chair of Clinical and Translational Research in the department of Neurology at University of Texas Southwestern Medical Center in Dallas. He holds a bachelor’s degree from Johns Hopkins, a master’s degree in molecular microbiology and immunology from the Johns Hopkins School of Public Health and graduated from Baylor College of Medicine. He served residency in neurology at The Johns Hopkins Hospital.

Morgan R. Brown is CFO at Clene. He has more than 30 years of finance and accounting experience, with 23 years at biotech, pharmaceutical and medical device companies. He has served in similar roles at Lipocine Inc., Innovus Pharmaceuticals, World Heart Corp., Lifetree Clinical Research and NPS Pharmaceuticals Inc. He previously worked at accounting firm KPMG. He is a CPA with a bachelor’s degree in accounting from Utah State University and an M.S. in business administration from the University of Utah.

Clene Inc. (NASDAQ: CLNN), closed Wednesday's trading session at $0.331, up 4.3835%, on 267,483 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.25/$1.09.

Recent News

Coyuchi Inc.

The QualityStocks Daily Newsletter would like to spotlight Coyuchi Inc.

ECGI (OTC: ECGI), a diversified holding company with a unique portfolio in viticulture and luxury fashion, today announced a major financial milestone. According to the update, the company has successfully secured the first of two $125,000 convertible note financings, a decisive move set to supercharge its strategic growth and expansion endeavors. The second convertible note is expected to close under the same terms next month. After fees, ECGI expects $100,000 in growth capital from each convertible note to support major initiatives. "I'd like to congratulate our dedicated investors who have shown unwavering support," said Jamie Steigerwald, CEO of ECGI Holdings. "2024 is shaping up to be a transformative year for ECGI. Securing this financing allows us to significantly enhance Pacific Saddlery's product development."

To view the full press release, visit https://ibn.fm/B6yW3

Coyuchi is the gold standard in sustainable luxury home goods. The company offers sustainably produced luxury organic bedding, sheets, towels, apparel, and other home goods for the environmentally conscious home. With a timeless, coastal-inspired aesthetic, Coyuchi uses only 100% organic cotton materials to manufacture all of its textiles.

The Company was built upon four foundational pillars: protect the planet, innovate circular design, live sustainably, and enrich the community. These guiding principles have proven an effective market strategy. In 2021, Coyuchi earned $33.3 million in net sales, amounting to 26% YoY growth (the industry average is only 5%). It also experienced 2x customer growth to 200,000 active customers, averaging a 35% customer repeat purchase rate.

With a seasoned leadership team, a robust e-commerce shopping experience, and a healthy customer base that drives the fast-growing organic luxury market, Coyuchi is prepared to propel a new phase of growth as the rest of the world finally awakens to sustainability at scale.

A Lucrative Market Ripe for the Taking

The global market for organic bedding, which was estimated at $814.3 million in 2020, is projected to reach $1.1 billion by 2027, growing at a CAGR of 4.9% over that period, according to Research and Markets. More specifically, the domestic organic bedding market is estimated at $240.1 million in 2020, according to Statista. Overall, the U.S. market for home textiles is currently valued at $25 billion annually, and, with a forecast annual growth rate of 5%, it is expected to reach $30 billion by the end of 2025.

Grand View Research reported in 2020 that shifting consumer preference toward high-end lifestyle products is a key factor driving the growth of the organic bedding market. Seventy-four percent of consumers are willing to pay more for sustainable products – a consumer preference that has steadily increased over the last few decades. Millennials especially favor ethical consumption over price when purchasing goods and services, with 83% of millennials reporting that they want the brands they purchase from to align with their beliefs and values (https://ibn.fm/PANNV). With a majority millennial customer base, Coyuchi is poised to capitalize on this trend.

Industry Defining Sustainability Practices

For 30 years, Coyuchi has explored organic farming and sustainable textiles and guarantees the highest environmental and ethical standards through a number of certifications such as The Global Organic Textile Standard (GOTS), Fair Trade Certified, and MADE SAFE®.

Coyuchi continues to push the organic textile market forward through its circularity initiatives and by supporting cross-industry sustainability advocates. Coyuchi’s mission to bring beauty and comfort to every home without sacrificing the health of our planet has resulted in a number of important sustainability checks and balances.

  • A Circular Business Model: Coyuchi has cultivated a holistic 360-degree approach that contributes to the fight against climate change with its take back and recycling program, 2nd Home™. In 2017, it became the first luxury home brand to implement such an initiative, and, since then, the company has eliminated 68,758 lbs. of toxic chemicals from homes and renewed 6,000 lbs. of textiles.
  • The Coyuchi Climate Council: In early 2022, Coyuchi introduced a cross-disciplinary council with a goal of Net Zero Emissions by 2025 and Net Positive Emissions by 2030. The Coyuchi Climate Council brings together influential minds across fashion, regenerative farming, and sustainability who have the knowledge and experience necessary to achieve climate change.
  • C4: The California Cotton & Climate Coalition: Most recently, Coyuchi announced it is a founding member of C4, which includes innovative, sustainable fashion, apparel, and personal care brands like MATE the Label, Outerknown, Reformation, and Trace. Working together pre-competitively, C4 creates a structure for investing in regionally grown, Climate Beneficial™ cotton and directly supports the livelihoods of the farmers that grew it. Coyuchi is the only home industry brand currently involved in the project.

Omnichannel Business Model

Coyuchi differentiates itself through an omnichannel and circular business model, both of which have proven a clear draw for customers. It was an early adopter of an e-commerce sales and marketing approach (over 80% of its sales are directly through coyuchi.com), creating a distinct advantage over incumbents and start-up newcomers in the luxury space. This has resulted in a high lifetime value customer, luxury retail partners such as Nordstrom, and a flagship store in Marin County.

Coyuchi’s Organic Textile Products

Coyuchi’s product assortment consists of consciously designed bedding, bath, apparel, and lifestyle products spread across about 1,400 SKUs. The company believes that its product assortment, produced from 100% organic cotton with Global Organic Textile Standard (GOTS) certification, provides it with a significant competitive advantage. GOTS is the world’s leading textile processing standard for organic fibers, ensuring the organic status of textiles after harvesting raw materials through environmentally and socially responsible manufacturing all the way to labeling, a major environmental and social benefit over conventional cotton product production.

Coyuchi’s focused product assortment consists of four core categories:

  • Bedding – A full suite of sustainable, organic, and high-quality sheets, duvet covers, blankets, and throws.
  • Bath – A luxurious line of towels, bath rugs, and mats.
  • Apparel – Premium apparel for men and women, including robes, sweaters, pants, and pajamas.
  • Lifestyle – The lifestyle category offers 135 SKUs, from organic napkins to crossbody totes.

Management Team

Eileen Mockus is President and CEO at Coyuchi. She has more than 25 years of experience in retail, having held positions in textile development at Patagonia, Pottery Barn Teen, and The North Face. She earned a bachelor’s degree in textiles and clothing from UC Davis and an MSBA from San Francisco State University.
Sejal Solanki is Chief Marketing Officer at Coyuchi. She previously served as the company’s Vice President of E-Commerce. Before joining Coyuchi, she worked at teen clothing giant Charlotte Russe. She oversees the company’s digital marketing, site experience, brand marketing, and e-commerce strategy.

Marcus Chung is Coyuchi’s COO, overseeing supply chain, sourcing strategy, sustainability, and IT. He previously held positions at notable direct-to-consumer brands Third Love and Stitch Fix, as well as national retailer The Children’s Place. He holds a bachelor’s degree from Wesleyan University and an MBA from UC Berkeley’s Haas School of Business.

Margot Lyons is Director of Sustainability and Sourcing at Coyuchi, where she works with strategic partners to ensure all the company’s product sustainability standards are met. She received a master’s degree in textiles and clothing from UC Davis.

Use of Proceeds

This round of funding will be used to increase Coyuchi’s enterprise value through expanded marketing, product category expansion, continued physical presence, and B2B strategic partnerships with wholesalers, and online marketplaces.

Recent News

chart

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

GEMXX (OTC: GEMZ) today announced its entry into a definitive agreement with Latin Energy Partners ("LEP") to drill four test wells in a highly promising geological formation in Latin America. The strategic venture marks a significant milestone in GEMXX's expansion into the energy sector, demonstrating the company's commitment to diversification and growth. According to the announcement, the project will be led by Dinesh Kumar Sarraf, the former chairman and managing director of India's premier exploration and production company, Oil and Natural Gas Corporation Ltd. "We are thrilled to collaborate with Latin Energy Partners and leverage Mr. Sarraf's unparalleled expertise in the oil and gas industry," said Richard Clowater, CEO of GEMXX Corporation. "This partnership aligns with our strategic goals of resource diversification and capitalizing on high-potential opportunities in the energy sector. The drilling of these test wells is a crucial step towards unlocking significant value for our shareholders."

To view the full press release, visit https://ibn.fm/f5QrQ

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has also collaborated with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has been granted patent protection for specific delivery of nicotine, vitamins, NSAIDs, antiviral drugs, cannabinoids and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Wednesday's trading session at $3.81, off by 4.75%, on 171,010 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.6488/$6.85.

Recent News

NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW)

The QualityStocks Daily Newsletter would like to spotlight NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW).

CEO Dr. Alan Baratz recently published a piece for the Forbes Technology Council that highlighted the transformation potential in bringing these two technologies together

D-Wave is helping companies explore the powerful combination of quantum computing with AI to drive innovation, reduce carbon emissions, and solve complex problems

As artificial intelligence ("AI") continues its rapid enterprise adoption trend, there is growing interest in how quantum computing can be used in conjunction with AI to create better, more cost- and energy-effective solutions in various fields, such as material science, logistics, and complex optimization problems. The way the two technologies could be used together is explored in a Forbes Technology Council column by D-Wave Quantum (NYSE: QBTS) CEO Dr. Alan Baratz (https://ibn.fm/kBjT6).

D-Wave Quantum Inc. (NYSE: QBTS) ("D-Wave"), a leader in quantum computing systems, software and services and the world's first commercial supplier of quantum computers, has posted a recording of its recent fireside chat at the 19th Annual Needham Technology, Media and Consumer Conference. The discussion between D-Wave CEO Dr. Alan Baratz, D-Wave CFO John Markovich and Needham senior analyst Quinn Bolton addressed a variety of topics related to D-Wave's leadership in the quantum computing industry, including its technical progress, why its annealing technology is more applicable to commercial applications, and how customers are using its solutions to address today's highly complex optimization problems.

To access the recorded fireside chat, visit https://ibn.fm/Qi0D4 or the D-Wave Investor Relations website.

To view the full press release, visit https://ibn.fm/opVT2

NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW), a next generation e-commerce platform, was created with vision and purpose to capitalize on high growth sectors and global markets. The company collaborates with businesses – large and small – to simplify and accelerate online commerce and uniquely enables customers and partners to optimize their e-commerce reach, presence and revenue. NextPlat recently launched a new e-commerce development program to provide American businesses with easy access to the massive Chinese consumer market.

Current Initiatives

NextPlat provides cutting edge technology in an advanced e-commerce ecosystem. The company is actively expanding its global network of online storefronts serving thousands of consumers, enterprises and governments. The company also has developed a next generation platform built for Web3 that enables the creation and sale of digital assets, as well as optimizing e-commerce transactions and business building activities. The company’s current initiatives include:

  • E-Commerce Development Program – In April 2023, NextPlat announced it had entered into a merchant sourcing agreement with Alibaba.com Singapore E-Commerce Private Limited (“Alibaba”) and its Tmall Global e-commerce platform whereby the two companies will collaborate to increase the sale of products produced and sold by American companies to the multi-trillion-dollar Chinese consumer market. Alibaba’s Tmall Global e-commerce platform will provide NextPlat customers a turn-key solution through which products can be sold to the Chinese consumer market. The launch of the Florida E-Commerce Development Program is the first in a series of new NextPlat programs designed to assist U.S. businesses in expanding their online sales capabilities to reach new international customers in the Chinese market. NextPlat intends to rapidly expand this unique e-commerce development opportunity to businesses throughout the United States and all of North America, as well as Central and South America. The new development program features NextPlat’s turnkey global e-commerce solution for customers and leverages NextPlat’s relationships with key partners, including Tmall Global, China’s largest cross-border B2C online marketplace.
  • Progressive Care Inc. – In August 2022, NextPlat completed a strategic $7 million investment in Progressive Care Inc. (OTCQB: RXMD), a personalized health care services and technology company. In a news release announcing the investment, NextPlat CEO Charles M. Fernandez noted that the company is “committed to harnessing the power of digital technologies to capitalize on the ongoing digital transformation of Progressive Care and the entire health care industry.” NextPlat intends to accelerate Progressive Care’s digital health care transformation with the launch of a new e-commerce platform for health care products later this year.
  • NextPlat NFT Platform – Building on its existing e-commerce initiatives, NextPlat is working to bridge the gap between tangible and digital e-commerce marketplaces by incorporating burgeoning Web3 technologies. The company intends to launch a fully integrated NFT platform in the coming months that will enable brands to create, manage and authenticate digital assets while serving as a new source of revenue for NextPlat. Through this model, the company will receive a portion of the revenue generated from branded NFT drops, as well as subsequent secondary market transactions.
  • Global Telesat Communications and Orbital SatCom Corp. – Targeting both domestic and international markets, NextPlat’s subsidiaries leverage partnerships with major e-commerce platforms such as Amazon, Alibaba, eBay and Walmart to serve a growing base that includes more than 50,000 corporate, governmental and individual customers. In total, the brands market more than 10,000 individual products, with a focus on satellite-based connectivity solutions. In addition to exploring accretive M&A opportunities, NextPlat aims to diversify its range of products and broaden its geographic footprint moving forward in an effort to better capitalize on the tremendous growth potential in the United States, Europe and Asia.

“Our goal for 2023 and beyond is to leverage our improved operational capabilities and enhanced leadership team as we expand our offerings in communications and connectivity into the high-growth health care market where we intend to launch an array of innovative new offerings,” Fernandez said in a March 2023 news release detailing the company’s record top-line performance. “Although there remain supply chain headwinds and the challenge of global inflation, we are confident that we have the right combination of market-tested expertise, technology and partnerships that will enable us to bring the power of e-commerce to more customers, brands and industries in the United States and abroad.”

Market Opportunity

The rapid growth of e-commerce over the last decade is expected to continue for the foreseeable future. According to data published by Forbes, roughly 20.8% of all retail purchases are expected to take place online in 2023, accounting for total sales of $6.31 trillion worldwide. It total, e-commerce sales are expected to grow by 10.4% YoY in 2023, accounting for a whopping 24% of all retail purchases by 2026.

For NextPlat, existing partnerships in the industry could be key to capitalizing on this growth. The Forbes report indicates that Amazon accounts for roughly 38.7% of e-commerce sales, while sites like Walmart, eBay and Alibaba round out the list of most visited e-commerce websites. Alibaba is especially interesting due to NextPlat’s recent strategic merchant sourcing agreement with Tmall Global. The Chinese market is “mammoth,” as a recent Alizila report noted. The country’s annual online retail sales of physical goods have nearly doubled in the last five years, reaching approximately 13.8 trillion yuan in 2022, which is nearly $2 trillion USD.

The health care portion of the e-commerce market is generating particularly bullish forecasts, bolstered by the continued adoption of the 340B Drug Pricing Program in the U.S., which requires most drug manufacturers to provide outpatient drugs to covered entities at significantly reduced prices. Industry reports suggest that the global health care e-commerce market will expand at a compound annual growth rate of 16.8% from 2022 to 2030, climbing to a value of more than $1.37 trillion by the end of the forecast period.

Management Team

Charles M. Fernandez, CEO, Executive Chairman and Director of NextPlat, has over three decades of experience in identifying profitable start-up and dislocation opportunities, building significant value and executing exit strategies as an entrepreneur and global investor. Successful across multiple sectors, Fortune Magazine actually labeled Fernandez ‘a restructuring whiz’. As President of Fairholme Capital Management, which he joined in 2008, Mr. Fernandez co-managed all three Fairholme funds and brought in a $2 billion gain for shareholders. Throughout his impressive career, he has participated in more than 100 significant mergers, acquisitions and product development projects across multiple industries. Mr. Fernandez was the founder, Chairman and CEO of eApeiron Solutions LLC, a brand protection and e-commerce company in partnership with Alibaba (NYSE: BABA) and Eastman Kodak (NYSE: KODK), which was successfully sold to Smartrac, a unit of Avery Dennison Corp. (NYSE: AVY).

Rodney Barreto is Chairman and CEO of the Barreto Group and Director of Nextplat. Mr. Barreto’s business career spans over 35 years, including his role at the Barreto Group and, earlier, as the founding partner of Floridian Partners LLC, a corporate and public affairs consulting firm recognized by policy makers as one of the top in its industry in Florida. He chaired the Super Bowl Host Committee in 2007, 2010 and 2020, helping to raise more than $100 million for the success of Miami Super Bowls. As a philanthropist and conservationist, Mr. Barreto is also a three-time appointee to the Florida Fish and Wildlife Conservation Commission, where he has served for over 10 years including holding the title of Chairman eight times. He has twice chaired the Annual U.S. Conference of Mayors, was Chairman of the 1999 Breeder’s Cup Championship held in South Florida and was the Chairman of the 1999 Sister Cities International Convention in Miami. Currently, Mr. Barreto is the Membership Chairman of the Florida Council of 100, and a member of the Boards of Fairchild Tropical Botanic Garden, the Baptist Health South Florida Giving Society, the Bonefish and Tarpon Trust, the Guy Harvey Ocean Foundation, and a member of Miami Dade County Schools Superintendent Carvalho’s Business Advisory Council. Prior to his career in public affairs and real estate, Mr. Barreto was a City of Miami police officer and is a member of the Florida Highway Patrol Advisory Council.

NextPlat Corp. (NXPL), closed Wednesday's trading session at $1.155, off by 2.1103%, on 34,170 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.06/$3.12.

Recent News

Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF)

The QualityStocks Daily Newsletter would like to spotlightFathom Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) .

Web3 is changing how businesses and consumers interact online. This next internet iteration leverages crypto to break new ground and generate unique global engagement and innovation opportunities. By utilizing crypto, marketing becomes more engaging, transparent and accessible. Web3 incorporates blockchain technology, decentralization and token-based economics. Unlike traditional marketing, the blockchain technology used in Web3 marketing allows for decentralization. Another way Web3 is using crypto is through blockchain-based advertising to ensure transparent and efficient marketing. The decentralized ledger records all transactions securely and transparently. For instance, Brave, an open-source browser, awards users with Basic Attention Tokens (BAT) rewards when they view ads on the platform. So, instead of ignoring ads, they can watch them and get paid for their time. This allows businesses to get real-time feedback on how their business is doing. In this way Web3, through crypto, is transforming how businesses reach more customers. As this approach keeps growing, it is clear that brands will have more opportunities to connect with more people in meaningful ways. Furthermore, the deployment of Web3 technologies by entities such as NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) will further entrench the utility of these technologies and draw even more public attention as the years go by.

Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) is a Canadian mineral and battery metals exploration and mining development company. Tartisan’s flagship asset is the Kenbridge Nickel Project. Located in the Kenora Mining District, in the Province of Ontario, the Kenbridge Nickel Project is an advanced staged nickel deposit with a measured, indicated and inferred resource and has an existing 622-meter three compartment shaft.

As the world looks to utilize electric vehicles (EVs) in an effort to reduce air pollution, demand for EV battery metals is on the rise. Nickel is one of these in-demand battery metals, and there are few new, high grade development projects ready to meet this opportunity. Silver, zinc, copper and even lead are also part of this transformation in the EV sector. Tartisan Nickel Corp. is an advanced stage mining development company in a mining friendly jurisdiction. The company is headquartered in Toronto, Ontario, Canada.

Projects

The company’s flagship Kenbridge Nickel Project is in the north-central part of the Atikwa Lake area and the south-central part of the Fisher Lake Area in the Kenora Mining District, approximately 70 kilometers east-southeast of the Town of Kenora in northwestern Ontario. The property is accessible via gravel roads from paved Highway 71. The Kenbridge Nickel Project is covered by patented and unpatented mining claims totaling 10,150 acres.

Tartisan’s project portfolio also includes:

  • The Don Pancho Manganese Silver Zinc Project is in a prolific polymetallic mineral belt in central Peru with several operating mines in the area, including the world-class Iscaycruz and Yauliyacu polymetallic mines, operated by Glencore Xstrata PLC, which are located 50 kilometers to the north-northwest. Additionally, Travail Mining Corporation’s Santander silver-lead-zinc mine is located just nine kilometers to the east and Buenaventura’s silver-lead-zinc Uchucchacua mine, which produced 10 million ounces of silver in 2011, is located 63 kilometers to the north.
  • The Turtle Pond Nickel Copper Project includes 105 staked units covering approximately 5,440 acres in northwestern Ontario, approximately 40 kilometers south of the town of Dryden in the Turtle Pond and Ukik Lake area. The claims are located approximately 70 kilometers east of the company’s flagship Kenbridge Nickel Project.
  • The Sill Lake Lead Silver Project is located approximately 30 kilometers north-northeast of Sault Ste. Marie in Vankoughnet Township in the Sault Ste. Marie Mining District of Ontario. The Sill Lake Property comprises 57 contiguous mining claims totaling approximately 2,850 acres.

Market Opportunity

A report by Grand View Research, a market research and consulting company, estimated the global nickel mining market to be worth $50.4 billion in 2022 and projected the market will grow to a value of more than $84.04 billion by 2030, achieving a CAGR of 6.6% over the forecast period.

Nickel alloy is a component of EV, portable electronics and power tool batteries. In addition, nickel is one of the key raw materials of stainless steel. Hence, development in the EV industry and growth in stainless steel end-use industries such as construction, consumer durables and machinery and equipment contribute to the growth of the market.

According to the Nickel Institute, the industry association for the world’s nickel producers, over two-thirds of the world’s nickel is currently utilized in the production of stainless steel.

Management Team

D. Mark Appleby is President, CEO and Director of Tartisan Nickel. He has more than 37 years of experience in a variety of disciplines relating to investment banking, corporate finance and capital markets. His career began at Manulife in the equity and fixed income departments. He later joined First Boston Canada, where he reached the position of Vice President, Bond Trading. Subsequently, he has worked as an investment executive with Scotia Mcleod Inc. and is co-founder of The Atlantis Group. He also served as a Director of Guyana Goldfields Inc. for five years.

Omar Gonzalez is CFO of Tartisan Nickel. He has over 20 years of experience in audit and assurance in South America, as well as five years of public and private audit practice, financial analysis and corporate development in Canada. He has led many assurance and non-assurance engagements for companies in the energy, mining and natural resources, real estate, manufacturing and consumer business sectors. He is a Chartered Professional Accountant in Venezuela and holds a bachelor’s degree in accounting from the Universidad Santa María in Caracas.

Tartisan Nickel Corp. (OTCQB: TTSRF), closed Wednesday's trading session at $0.13, off by 7.1429%, on 10,500 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.04685/$0.1905.

Recent News

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF)

The QualityStocks Daily Newsletter would like to spotlight Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF).

Freight Technologies (NASDAQ: FRGT) ("Fr8Tech") is an innovative logistics technology solutions company offering its custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine learning that offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region. The company has announced a significant milestone in the expansion of its Fr8Radar module in the first half of 2024, having successfully integrated with 15 new GPS providers, bringing the total number of GPS integrations to 28. "At Freight Technologies, we are committed to advancing the logistics industry through cutting-edge technology," said Javier Selgas, chief executive officer of Freight Technologies. "The recent expansion of Fr8Radar significantly enhances our platform's capability to provide real-time visibility and security for our clients. This is particularly crucial for the Mexican over-the-road transportation industry and cross-border logistics involving Mexico, where the risk of cargo theft is a significant concern."

To view the full press release, visit https://ibn.fm/9bka2

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) is a strategic minerals company focused on locating and developing economic properties in the strategic metals and advanced materials space. The company aims to improve domestic specialty mineral infrastructure efficiencies to meet surging national demand from North American manufacturers, effectively positioning itself as one of the only North American suppliers of high purity natural graphite for hi-tech applications.

Reflex Advanced Materials is based in Vancouver, British Columbia. Its project portfolio includes the Ruby Graphite Deposit in Montana and the ZigZag Lithium Property in Ontario.

Projects

Ruby Graphite Project

Located in a mining-friendly jurisdiction in southwest Montana, the Ruby Graphite Deposit is a low cost, rapid re-entry opportunity that produced roughly 2,400 tons of graphite from 1902 to 1948. Reflex Advanced Materials holds mining rights for 755 hectares at the Ruby Graphite Project, with 96 federal lode mining claims. Recent samples assay at 95.8% to 98.4% total carbon.

The site is notable as the only combined U.S. graphite flake and vein graphite source. Vein graphite is ideal for energy storage applications, because it requires fewer steps to achieve purity than synthetic alternatives and is therefore far less environmentally damaging. This is expected to play a key role in the project’s development as demand for electric vehicles continues to surge.

In March 2023, the company announced its submittal of permit applications to the Bureau of Land Management in respect of its exploration of the Ruby Graphite Project. Its initial drill program, expected to take place in the summer of 2023, includes plans for 3,500 total meters of drilling, cored to an average depth of 130 meters. The targets for this drill program have been identified using historical data from original mine operations and data gathered for the initial 43-101 technical report on the project, dated January 31, 2023.

ZigZag Lithium Property

Located in the Thunder Bay Mining Division of Ontario, the ZigZag Lithium Property consists of eight mining claims spanning roughly 2,710 hectares. Mineralization at the property, most notably lithium, is based in pegmatite dikes and concentrated in spodumene crystals, which are consistent throughout the entire unit.

Spodumene is readily observable in outcrops and in drill cores, with crystal sizes ranging from 3-15cm, on average.

Reflex Advanced Materials and American Energy Technologies Company Metallurgical Partnership

Reflex Advanced Materials has entered into a material processing agreement with American Energy Technologies Co., which is based in Arlington Heights, Illinois, to conduct metallurgical testwork with the goal of creating a technical support data package for Reflex’s target customer base, U.S. Federal agencies and qualification programs with hi-tech customers in the battery and battery storage business.

The resulting coated, spherionized, purified graphite (CSPG) material that is expected to be created from the aforementioned tests will be used to provide potential customers of CSPG with samples so that they can begin the material qualification process.

Market Opportunity

Graphite is an ideal battery anode and has dominated the market since the proliferation of lithium-ion batteries. Despite this demand, there is currently no significant production of lithium-ion battery anode material in North America.

Instead, most graphite sold in North America today is sourced from Chinese producers. U.S. President Joe Biden highlighted this sourcing disparity in a 2022 address:

“The United Stated depends on unreliable foreign sources for many of the strategic and critical materials necessary for the clean energy transition – such as lithium, nickel, cobalt, graphite and manganese for large-capacity batteries,” he said. “Demand for such materials is projected to increase exponentially as the world transitions to a clean energy economy.”

The U.S. Department of Energy is in the process of awarding $2.8 billion to expand domestic manufacturing of batteries for electric vehicles and combat this foreign dependency. Reflex Advanced Materials has identified its Ruby Graphite Project as a prime candidate for U.S.-sponsored initiatives due to the rarity and scarcity of natural graphite deposits in the country.

Processing graphite domestically in the U.S. is expected to provide Reflex Advanced Materials a competitive advantage as manufacturers begin to seek out American supply in the face of increased diplomatic tension. This is critical, as a rise in anode demand is expected to fuel a shortage of 8 million tonnes of graphite by 2040. World Bank Group projects 494% growth in total graphite demand by 2050.

Leadership Team

Paul Gorman is the CEO and a Director of Reflex Advanced Materials. He brings to the company over 25 years of experience in junior mining finance, public listings, viability assessment and operational rationalization. For 18 years, Mr. Gorman served as president and managing partner of Riverbank Capital, where he played an instrumental role in raising more than $85 million for small-cap companies. In 2008, he funded Industrial Minerals Inc. (later Northern Graphite) and served in an advisory role for four other graphite companies, contributing significantly to the revitalization of the junior graphite space in North America. Mr. Gorman founded Mega Graphite Inc. in 2009 and has served as chief executive for three other companies.

Tasheel Jeerh, CPA, is the company’s CFO. He is a finance and accounting professional with over a decade of experience spanning both public and private sectors. Prior to joining Reflex Advanced Materials, Mr. Jeerh played a pivotal role in the growth of a private upstream oil and gas firm, dealing with over $2 billion in M&A activity and $1 billion in financing activities. He gained his designation at PricewaterhouseCoopers, where he worked as a manager in the assurance practice.

Greg Bell is Project Manager for Reflex Advanced Materials. He is a multi-disciplined engineering management professional with more than 40 years of experience in the natural resources sector. Mr. Bell has successfully built and managed several start-up operations in various capacities. He has been active in graphite and lithium exploration for the past seven years.

Christopher W. Hill leads the company’s Corporate Development initiatives. He is an investor and entrepreneur with over a decade of experience in the capital markets. Mr. Hill began his career as an investment advisor and then began to consult and advise private companies on their paths to becoming publicly traded. He specializes in corporate development and strategic financing utilizing his large network in the capital markets.

Reflex Advanced Materials Corp. (RFLXF), closed Wednesday's trading session at $0.0648, off by 7.2961%, on 35,310 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0567/$0.35.

Recent News

HealthLynked Corp. (OTCQB: HLYK)

The QualityStocks Daily Newsletter would like to spotlightFathom HealthLynked Corp. (OTCQB: HLYK) .

HealthLynked Corp. (OTCQB: HLYK) is at the forefront of a transformative movement in healthcare, utilizing its extensive collection of health data to improve care for all. With a commitment to leveraging its advanced technology platforms, HealthLynked employs a sophisticated, cloud-based network that serves as a comprehensive repository for personal health data. This system not only simplifies the management and archiving of medical records but also enables the application of AI to deliver personalized healthcare insights. Through deep analysis of this data, HealthLynked’s AI capabilities help identify the root causes of diseases, tailor healthcare solutions to individual needs, and accelerate medical discoveries.

HealthLynked Corp. App

In addition to these capabilities, HealthLynked provides a user-friendly platform for booking healthcare appointments, similar to how OpenTable operates for restaurant reservations. This feature allows patients to conveniently book appointments with healthcare providers across the country, including options for telemedicine consultations, enhancing accessibility and efficiency in healthcare service delivery.

Strategically headquartered in Naples, Florida, HealthLynked operates through three primary divisions: Health Services, Digital Healthcare, and Medical Distribution. Each division supports the company’s mission to revolutionize patient care and health management. Positioned as a potential leader in healthcare AI, HealthLynked is dedicated to shaping the future of the industry over the next 20 years, driving significant advancements in healthcare accessibility and effectiveness through innovation and technology.

HealthLynked Corp. Reach

Strategic Initiatives and Operational Highlights

The company’s commitment to enhancing global health is evident in its dual goals: transforming healthcare through advanced technology and creating a patient-centric network that accelerates medical discoveries and the development of disease cures.

HealthLynked’s intellectual property portfolio is robust and strategically developed to enhance healthcare delivery and management. In March 2023, HealthLynked was granted a patent for a groundbreaking healthcare-specific wireless access point, known as the “Patient Access Hub.” This technology significantly improves the efficiency of healthcare practices by enabling real-time monitoring of patient flow within facilities. It intelligently determines patients waiting in exam rooms and calculates wait times, alongside other critical practice metrics. This system not only enhances patient experience by reducing unnecessary wait times but also optimizes resource allocation within healthcare settings.

Additionally, in October 2023, HealthLynked filed a patent application for its advanced AI program, ARI (Augmented Real-time Interface). ARI acts as a virtual doctor for patients, capable of performing medical intake, booking appointments, and providing personalized medical recommendations based on a patient’s medical history. By integrating these tasks, ARI streamlines the healthcare process, reducing the administrative burden on healthcare providers and ensuring that patients receive timely and tailored healthcare advice. This AI-driven interface enhances the accessibility and personalization of healthcare, embodying HealthLynked’s commitment to leveraging technology for better health outcomes. The company recently launched HealthLynked 3.2.0, an advanced version of its application, incorporating telemedicine, AI-driven personal healthcare guidance, and remote patient monitoring – setting a new standard in healthcare technology.

Market Position and Future Outlook

According to Facts and Figures Research, a research and consulting firm, the global market for patient-centric healthcare applications is projected to reach $41.6 billion by 2030, growing at a CAGR of 18.77% from 2022. HealthLynked’s offerings align perfectly with this expansive market opportunity, especially with increasing demands for digital health solutions and data management in healthcare.

HealthLynked’s strategic direction, spearheaded by its seasoned management team, is designed to leverage these market dynamics, enhancing patient engagement and healthcare efficiency on a global scale.

Management Team

Michael T. Dent, M.D., Founder, CEO, and Chairman, brings extensive experience from his foundational role at NeoGenomics and leadership in various healthcare and technology sector companies.

David Rosal, CFO, with previous senior roles at Teradata and McDonald’s Corporation, brings a wealth of expertise in financial and business integration strategies essential for growth and operational efficiency.

Chris Hall, CTO, with a strong background in global technology development from his time at Siemens and several patents to his name, is instrumental in driving the innovation and technological advancement at HealthLynked.

Bill Crupi, Operations Manager, has a proven track record in streamlining operations and enhancing productivity across multiple sectors within the healthcare industry. His expertise is crucial in maintaining the operational excellence that HealthLynked is known for.

Michael Paisan, Director of Investor Relations, leverages his extensive experience in finance and communications to enhance HealthLynked’s relationships with investors and stakeholders, ensuring transparent and effective communication of the company’s value and growth strategy.

Gagan Babber, Manager of Software Development, oversees the HealthLynked development teams based in the U.S. and India. With a robust background in engineering and software development, he plays a critical role in guiding the technological direction of HealthLynked’s products. His expertise in developing scalable, innovative software solutions is essential for driving the company’s technical initiatives forward and ensuring that HealthLynked stays at the forefront of digital healthcare technology.

HealthLynked Corp. (OTCQB: HLYK), closed Wednesday's trading session at $0.05415, off by 4.4974%, on 71,416 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.033/$0.0999.

Recent News

Nightfood Holdings Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings Inc. (OTCQB: NGTF).

Nightfood Holdings Inc. (OTCQB: NGTF) is a visionary holding company focused on identifying and capitalizing on explosive market trends within hospitality, food services and consumer packaged goods. By leading newly emerging categories and seizing opportunities in markets undergoing transformational upheaval, the company’s mission is to create unparalleled upside potential in industries ripe for innovation and growth.

Subsidiaries

Nightfood Inc.

The company’s flagship subsidiary, Nightfood Inc., is changing the way the world snacks at night. Humans are biologically hard-wired to crave sweets and fats at night – a survival mechanism from our hunter-gatherer days. Modern consumers know bingeing excess calories before the long nightly fast is no longer necessary for survival, but exploding screen time and decreased willpower at night results in over 90% of American adults snacking between dinner and bed every week, contributing to an estimated one billion nighttime snack occasions weekly (according to SleepFoundation.org).

The most popular choices – ice cream, cookies, chips and candy – are not only unhealthy but also impair sleep quality due to their nutritional profiles. Nightfood snacks are uniquely formulated by sleep and nutrition experts to satisfy nighttime cravings AND support better sleep.

Market Opportunity

Euromonitor International projects the American snack market will grow from $150 billion in 2022 to $170 billion in 2027. Snacking between dinner and bed is estimated to account for over $60 billion annually, creating an opportunity for a multi-billion-dollar sub-category to emerge in the coming years: sleep-friendly snacking.

Nightfood is the brand pioneering that category.

Nightfood’s innovation has led to partnership overtures from global giants, including the largest food and beverage company in the world, Nestlé, with whom Nightfood completed a “test-and-learn” joint initiative in 2023.

Management believes that successfully scaling Nightfood’s 2024 direct-to-consumer launch of sleep-friendly cookies will bring the category to life, opening the door for partnerships with and potential acquisition by global snack giants seeking to lead this potential billion-dollar emerging sub-category.

Future Hospitality Ventures Holdings Inc. (d/b/a roboOp365)

Future Hospitality Ventures Holdings, operating under the brand roboOp365, is revolutionizing the hospitality industry with cutting-edge automation and robotic solutions.

roboOp365 enhances operational efficiency and guest experiences through innovative technologies, including automated culinary bot, server robots and AI-enhanced applications. roboOp365 helps hospitality providers reduce costs, streamline operations and deliver superior service by integrating these advancements.

Market Opportunity

The robots-as-a-service (RaaS) business model has gained significant traction, super-charged by the COVID-19 pandemic, which instantly catalyzed game-changing growth and application. According to Verified Market Research, the service robotics market is projected to reach $173.17 billion by 2030, growing at a compound annual growth rate (CAGR) of 21.25%. Compared to Asia, the United States market is in the early stages of adopting these technologies, but acceptance is accelerating aggressively.

Several factors are driving this trend. Key industries such as hotels and restaurants are still struggling to rebound from the pandemic’s impact, hoping to return to pre-pandemic levels, if possible. Such recovery will largely be dependent upon service robots. In California specifically, factors such as rising labor costs, more rigorous labor laws and ongoing high turnover rates in labor-intensive sectors make it impossible for businesses to survive, thrive and compete without robotics.

Innovation Across Sectors

Nightfood Holdings Inc. is dedicated to driving innovation across its focus sectors of food services, automation and hospitality applications. In food services, the company leverages automation technology to drive operational efficiency for operators while meeting evolving consumer needs. In the hospitality industry, it’s deploying solutions that redefine guest experiences. Nightfood’s consumer-packaged goods initiatives are key to breakthrough trends in health and wellness.

Synergizing Food and Technology

The synergy of food and technology within Nightfood Holdings Inc. creates a holistic approach to innovation and automation. By integrating these areas, the company offers comprehensive solutions that address multiple facets of market needs. Its automation and artificial intelligence solutions in food service and hospitality create a seamless and enhanced consumer experience.

Through this integrated approach, Nightfood Holdings Inc. not only meets current market demands but also anticipates and influences future trends, positioning itself as a leader in innovation across these interconnected sectors. Synergies in these related and explosive categories result in operational efficiency and benefits for the company’s customers and partners and outsized upside and opportunity for its investors.

Management Team

Sean Folkson is the Chairman and President of Nightfood. He founded Nightfood when he couldn’t find a solution to his nighttime snacking problem. Recognizing the growing body of research linking nutritional intake with sleep quality, he launched the first snack brand specifically formulated to give consumers better, healthier and more sleep-friendly snacks for that peak-cravings slot between dinner and bed. He is a serial entrepreneur and problem-solver, having previously founded Specialty Equipment Direct, an online distributor of floor removal equipment, and AffiliatePros.com, a pioneering company in online affiliate marketing.

Lei Sonny Wang is the CEO of Nightfood Holdings. He is a strategist and business driver for early-stage and growth-stage companies. He is the founder and former CEO of Future Hospitality Ventures Holdings Inc., which was acquired by Nightfood Holdings Inc. At Future Hospitality, he leveraged his significant international business development experience into distribution relationships with leading global robotics manufacturers. At Nightfood, he is working to grow revenue and improve performance and profitability across all subsidiaries.

Nightfood Holdings Inc. (OTCQB: NGTF), closed Wednesday's trading session at $0.0155, off by 2.8213%, on 63,617 volume. The average volume for the last 3 months is 205,753 and the stock's 52-week low/high is $0.0075/$0.055352.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Wednesday's trading session at $3.52, off by 7.3684%, on 2,354,562 volume. The average volume for the last 3 months is 4.559M and the stock's 52-week low/high is $2.3565/$661.50.

Recent News

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF)

The QualityStocks Daily Newsletter would like to spotlight First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) .

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) is committed to exploring for and providing essential and critical metals, including tellurium, gold, silver, copper and tungsten, for North American markets. This objective is anchored by the company’s Deer Horn tellurium-gold-silver-copper project in British Columbia, Canada, and further enhanced by its property option on the Klondike tellurium-gold prospect located in Colorado, USA.

First Tellurium’s unique business model is to generate revenue and value through mineral discovery, project development, project generation and cooperative access to untapped mineral regions in indigenous territory with sustainable exploration potential.

The company is headquartered in Vancouver, British Columbia.

Tellurium and the Green Energy Revolution

Tellurium has a key role to play in the ongoing green energy revolution. It is widely used in the manufacturing of photovoltaic cells for solar panels.

Despite this utility, ongoing trade tensions between China and the U.S. create implications for both tellurium and the production of cadmium-tellurium solar cells. Earlier this year, China announced plans to restrict exports of critical metals gallium and germanium, both essential for the production of semiconductors. For reference, China produces around 80% of the world’s gallium and approximately 60% of the world’s germanium.

China’s recent trade restrictions amplify the fragility of the North American tellurium supply, as the Asian nation currently produces about 60% of the world’s tellurium. This sustained supply vulnerability is why First Solar, the United States’ largest solar panel producer, set up a worldwide search for tellurium deposits in the mid-2000s.

“In North America alone, our understanding is that First Solar looked at over a hundred tellurium properties,” First Tellurium CEO Tyrone Docherty stated in a news release. “Their number one property by far, which they acquired, was the Colorado Klondike which we now control.”

The U.S. is now looking to secure safe, domestic sources of tellurium and many other critical metals to pre-empt potential shortages. The Biden administration has instituted a stream of policies, particularly the U.S. Inflation Reduction Act, to source solar components from North America and other “friendly” jurisdictions.

As the only junior mining company in the world focused on tellurium exploration, First Tellurium is ahead of the curve in capitalizing on these initiatives to establish strategic, domestic supplies of key resources for solar panel manufacturers.

First Tellurium’s ESG Initiatives

Through its exploration and partnerships with Fenix Advanced Materials, Cheona Metals and IRMA, First Tellurium strives to generate a measurable, beneficial social or environmental impact alongside a financial return. The company conducts a diversified search for metals, working in alliance with indigenous peoples, NGOs, governments and leading metals buyers. First Tellurium believes this is the future of mineral exploration — generating revenue by exploring responsibly and leveraging diverse partnerships.

First Tellurium proudly adheres to, and supports, the principles and rights set out in the United Nations Declaration on the Rights of Indigenous Peoples and, in particular, the fundamental proposition of free, prior and informed consent.

 

Projects

Deer Horn Tellurium-Gold-Silver-Copper Project

Deer Horn is located on 51.33 square kilometers (km) in west-central British Columbia, 36 km south of the prolific Huckleberry copper-molybdenum mine and 135 km southwest of the community of Burns Lake. It is one of few significant tellurium discoveries outside Asia and includes a 2.4 km-long vein system of high-grade gold, silver and tellurium, as well as broader zones of bulk-tonnage gold, silver and tellurium mineralization. The company completed a positive Preliminary Economic Estimate and has begun permitting for a 10,000-tonne bulk sample program to advance the project toward mine feasibility. It is North America’s only silver-gold-tellurium property with an NI 43-101 compliant tellurium resource, and it hosts a number of other mineralized targets and zone containing critical metals such as copper, tungsten and zinc.

First Tellurium owns 50% of the property, with an option to acquire up to a 75% interest. The company has engaged Dias Geophysical of Saskatoon, Saskatchewan, to conduct induced polarization (IP) geophysics on the Deer Horn Project in summer 2023. The program is designed to help develop drill targets for a subsequent drilling program.

Klondike Gold-Tellurium Project

The Klondike property is located in Saguache County, Colorado, southwest of Buena Vista in the state’s historical mining district. The company reports it has engaged Burgex Mining Consultants of Sandy, Utah, to stake additional claims around the Klondike property. The claims have been filed with the Bureau of Land Management.

Klondike demonstrates exceptional tellurium grades. Tellurium, used in high-efficiency cadmium telluride (Cd-Te) solar panels, next-generation lithium-ion batteries and thermoelectric devices to change heat into energy, is an essential element for the world’s transition to green energy.

The Klondike property was a top tellurium prospect owned previously by First Solar Inc., one of the world’s largest solar panel producers. First Solar terminated its worldwide raw materials exploration program in 2012 and sold the property to Colorado Klondike LLC, which optioned the project to First Tellurium. Colorado Klondike, led by First Solar’s former Exploration Manager in North America, is managing the upcoming exploration program.

The Colorado Geological Survey (CGS), in partnership with the Colorado School of Mines, reported on First Solar’s exploration at Klondike in 2015, noting: “Surface sampling by First Solar, Inc. in 2006 found very high tellurium grades of up to 3.3% (33,000 ppm), along with locally high gold grades. Tellurium grades at Klondike were the highest encountered in the company’s nationwide exploration program.”

Market Outlook

First Tellurium in spring 2023 referenced recent forecasts by the International Energy Agency (IEA) pointing to rapid growth in solar photovoltaic (solar PV) deployment worldwide. According to the agency, solar PV installations will generate more power by 2027 than any other energy source, including coal, natural gas and hydro. To meet this demand, consumption of both silver and tellurium, key components of solar panels, is expected to surge in coming years.

Chen Lin, founder of Lin Asset Management, has written in his investment newsletter for clients that solar PV is now the largest industrial usage of silver. He said that in 2022 solar PV production used about 12% of total silver demand, or about 120 million ounces of silver. Lin expects this number to rise dramatically in the coming years, and that is likely to lead to silver supply deficits for decades to come.

Lin points out that solar power is now the cheapest source of energy in many parts of the world and that all forecasts point to dramatic expansion of solar PV in the coming two decades. Conservative estimates forecast 300 gigawatts of solar PV production by 2027, up from the current level of about 200 gigawatts.

Management Team

Tyrone Docherty is President, Director and CEO of First Tellurium Corp. He previously served as President and CEO of Quinto Mining Inc., taking over when it had a market cap of $4 million. With limited resources in a difficult market environment, he raised more than $30 million and advanced Quinto’s Quebec iron ore property to a viable project. Quinto later sold for $175 million, with Quinto management taking shares of the purchaser, Consolidated Thompson Iron Mines, amounting to approximately 20-21% of that company. Consolidated Thompson Iron Mines sold two years later for $4.9 billion, giving the former Quinto team an enterprise value of approximately $1 billion. From 2012 to 2018, Mr. Docherty was Director and Chairman of Mason Graphite Inc. He has worked in the financial and minerals markets for more than 30 years.

Tony Fogarassy, M.Sc. LL.M., is Chairman of First Tellurium Corp. He is a lawyer and a geologist. His extensive legal and technical expertise includes minerals, oil and gas, coal and renewable energy projects and environmental and aboriginal/indigenous law in North America, Africa and Asia. He graduated as gold medalist in geological sciences from the University of British Columbia and in law from the London School of Economics.

First Tellurium Corp. (OTCQB: FSTTF), closed Wednesday's trading session at $0.09, up 4.6512%, on 61,477 volume. The average volume for the last 3 months is 71,714 and the stock's 52-week low/high is $0.047785/$0.134.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.